OriGene Technologies, Inc.
Search:    
About FL cDNA Clones RNAi Gene Expression Lysates and Proteins Antibodies Tissue Other Products Tech Support
orange


OriGene TissueScan in recent publications
Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies J. Clin. Endocrinol. Metab., Dec 2011; 96: E2023 - E2028. [four normal thyroid tissue specimens ]

QKI-Mediated Alternative Splicing of the Histone Variant MacroH2A1 Regulates Cancer Cell Proliferation Mol. Cell. Biol., Oct 2011; 31: 4244 - 4255. [Breast Tissue RNA]

Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J Mol Diagn. 2011 Sep;13(5):493-503. [Tumor Tissue]

Inhibition of miR-193a Expression by Max and RXRa Activates K-Ras and PLAU to Mediate Distinct Aspects of Cellular Transformation Cancer Res., Aug 2011; 71: 5144 - 5153. [RNAs from colon adenocarcinomas  ]

Tissue Microarray (TMA)

Quality tissue arrays for your high-throughput molecular analysis

divider

TMA Image

Tissue microarrays (TMAs) are created from high-quality tissue samples from the OriGene Tissue Biorepository, a growing collection of over >140,000 tissue samples, molecular derivatives, and associated clinical data that represent hundreds of pathology diagnoses.

Our high-quality tumor progression TMAs are produced using formalin-fixed paraffin-embedded (FFPE) tissue samples.

  • Collected under the highest bioethical guidelines using strict IRB-approved protocols from accredited medical institutions in the US.
  • Tissue samples were tracked and maintained in a rigorously monitored environment, using the most sophisticated automated biospecimen management software
  • Sample cores selected by board-certified pathologists.
  • TMA Datasheet/Map includes H&E images and detailed pathology reports with histological subtypes, and TNM staging.
  • Fully qualified for IHC analysis and suitable for in situ hybridization (ISH) analysis.
  • TMA sections freshly-cut prior to shipment.
ItemSpecificationsClinical DataTMA Map
Cancer Survey Tissue Microarray New! FFPE, 165 x 1 mm cores, 110 tumors and 55 normals, covering 11 cancer types: Breast, Colon, Lung, Kidney, Ovarian, Endometrial, Stomach, Prostate, Melanoma, Liver, Lymphoma. Datasheet TMA Map

ItemSpecificationsClinical DataTMA Map
Colon Cancer Tissue Microarray FFPE, 50 x 1 mm cores, 40 tumors and 10 normals Datasheet TMA Map
Lung Cancer Tissue Microarray FFPE, 50 x 1 mm cores, 40 tumors and 10 normals Datasheet TMA Map
Ovarian Cancer Tissue Microarray FFPE, 50 x 1 mm cores, 40 tumors and 10 normals Datasheet TMA Map
Kidney Cancer Tissue Microarray FFPE, 50 x 1 mm cores, 40 tumors and 10 normals Datasheet TMA Map
Breast Cancer Tissue Microarray FFPE, 42 x 1 mm cores, 36 tumors and 6 normals Datasheet TMA Map
Normal Tissue Microarray FFPE, 50 x 1 mm cores, covering 25 different tissues, 2 donors per tissue type Datasheet TMA Map

The following TMAs were specifically designed to match OriGene TissueScan cancer first-strand cDNA arrays. Use our TissueScan qPCR arrays to reveal gene expression profiles across disease stages, while also assessing expression of proteins with our matched TMAs below.

TMA matched to OriGene TissueScan qPCR panels
Colon Cancer Tissue Microarray matched to TissueScan qPCR array HCRT101 FFPE, 48 x 1 mm cores (43 tumors and 5 normals) Datasheet TMA Map
Ovarian Cancer Tissue Microarray matched to TissueScan qPCR array HORT101 FFPE, 48 x 1 mm cores (41 tumors and 7 normals) Datasheet TMA Map

Related Products

 

divider
Inc 5000 Healthcare Company Copyright © 2012 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436


Reproduction of any materials from this website is strictly forbidden without permission.